The role of leukemia inhibitory factor in regulating angiogenesis-related gene expression in a mouse model of recurrent miscarriage
Placenta · 2025
DOI: 10.1016/j.placenta.2025.04.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2025. Verfasst von Zahra Allahyari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Genetics, Faculty of Science, Science and Arts University, Yazd, Iran. Hauptthemen laut MEDLINE: Leukemia Inhibitory Factor, Abortion, Habitual, Neovascularization, Physiologic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Shahid Sadoughi University of Medical Sciences.
Abstract (Originalsprache)
BACKGROUND: Recurrent miscarriage is an early pregnancy complication that affects approximately 1-3 % of pregnant couples. Leukemia Inhibitory Factor (LIF) plays an important role in various biological processes, including angiogenesis and pregnancy. This study aimed to evaluate the role of LIF in regulating angiogenesis-related genes in a mouse model of recurrent miscarriage. METHOD: Female CBA/J mice mated with DBA/2J males were utilized as a miscarriage model. The study population was randomly assigned to three groups, normal group, mating female CBA/J mouse with male Balb/c without injection; miscarriage model control group with PBS injection; and the miscarriage group, in which LIF was injected. Following detection of a vaginal plug, mice were dissected on days 4, 7, and 14 of pregnancy. Uterine and placental tissues were collected to assess the expression of angiogenesis-related genes, including VEGF, PDGF, ANG1, FGF, and TGF-β, using real-time PCR. RESULT: Data analysis revealed no significant differences in the expression of angiogenesis-related genes on days 4 and 7 of pregnancy compared with the control group. However, on day 14 of pregnancy, the expression of VEGF and TGF-β was significantly elevated in the miscarriage group receiving LIF compared to other groups (P = 0.03 and P = 0.04, respectively). The placental expression of the studied genes also exhibited a non-significant increase in the miscarriage group, with VEGF and TGF-β showing the most prominent increases, although these changes were not statistically significant. Correlation analysis between uterine and placental gene expression on day 14 revealed no significant association. CONCLUSION: LIF regulates the uterine and placental expression of angiogenesis-related genes, particularly VEGF and TGF-β. These findings highlight the role of LIF in regulating angiogenesis-related gene expression and suggest that LIF could be a potential therapeutic candidate for improving pregnancy outcomes in cases of recurrent miscarriage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Genetics, Faculty of Science, Science and Arts University, Yazd, Iran.
- Developmental Biology, Biology Department, Faculty of Science, Science and Arts University, Yazd, Iran. Electronic address: nikoonahad@sau.ac.ir.
- Reproductive Immunology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Electronic address: fatemezare91@gmail.com.
Förderung
- Shahid Sadoughi University of Medical Sciences
Zitieren
APA
Allahyari, Z., Lotfabadi, N. N., & Zare, F. (2025). The role of leukemia inhibitory factor in regulating angiogenesis-related gene expression in a mouse model of recurrent miscarriage. Placenta. https://doi.org/10.1016/j.placenta.2025.04.009
Vancouver
Allahyari Z, Lotfabadi NN, Zare F. The role of leukemia inhibitory factor in regulating angiogenesis-related gene expression in a mouse model of recurrent miscarriage. Placenta. 2025. doi:10.1016/j.placenta.2025.04.009
BibTeX
@article{Allahyari2025,
author = {Allahyari, Zahra and Lotfabadi, Narges Nikoonahad and Zare, Fateme},
title = {The role of leukemia inhibitory factor in regulating angiogenesis-related gene expression in a mouse model of recurrent miscarriage},
journal = {Placenta},
year = {2025},
doi = {10.1016/j.placenta.2025.04.009}
}
EUVIMED